The improved therapeutic effects of adefovir dipivoxil in patients with HBeAg-negative chronic hepatitis B offset against its increased cost compared to lamivudine

被引：1
|
作者：
Buti, M.
Casado, M. A.
Calleja, J. L.
Salmeron, J.
Guilar, J. A.
Rueda, M.
Esteban, R.
机构：
[1] Hosp Gen Valle Hebron, Dept Internal Med, Liver Unit, Barcelona, Spain
[2] Pharmacoecon & Outcomes Res, Madrid, Spain
[3] Hosp Puerto Hierro, Madrid, Spain
[4] Hosp Clin San Cecilio, Granada, Spain
[5] Hosp Virgen Del Rocio, Seville, Spain
[6] Gilead Sci Inc, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80485-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
485
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 409 - 419
  • [2] Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients
    Rapti, Irene N.
    Dimou, Evangelini
    Mitsoula, Panayota
    Hadziyannis, Stephanos J.
    HEPATOLOGY, 2006, 44 (04) : 558A - 559A
  • [3] Cost-effectiveness of two oral antiviral therapies, lamivudine and adefovir dipivoxil of HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 172 - 172
  • [4] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    HEPATOLOGY, 2009, 50 (04) : 520A - 521A
  • [5] Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, P
    Vigano, M
    Manenti, E
    Lunghi, G
    Iavarone, M
    Del Ninno, E
    Colombo, M
    JOURNAL OF HEPATOLOGY, 2005, 42 : 182 - 182
  • [6] Long term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Bhushan, B.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
  • [7] Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B
    Sung, Joseph J. Y.
    Lai, Jak-Yiu
    Zeuzem, Stefan
    Chow, Wan Chen
    Heathcote, E. Jenny
    Perrillo, Robert P.
    Brosgart, Carol. L.
    Woessner, Mary A.
    Scott, Susan A.
    Gray, D. Fraser
    Gardner, Stephen D.
    JOURNAL OF HEPATOLOGY, 2008, 48 (05) : 728 - 735
  • [8] Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    HEPATOLOGY, 2005, 42 (04) : 354A - 354A
  • [9] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Ma, J
    Arterburn, S
    Xiong, S
    Currie, G
    Brosgart, CL
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2673 - 2681
  • [10] Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, Pietro
    Marzano, Alfredo
    Levrero, Massimo
    Santantonio, Teresa
    Di Marco, Vito
    Brunetto, Maurizia
    Andreone, Pietro
    Sagnelli, Evangelista
    Fagiuoli, Stefano
    Mazzella, Giuseppe
    Raimondo, Giovanni
    Gaeta, Giovannibattista
    Ascione, Antonio
    HEPATOLOGY, 2006, 44 (04) : 693A - 694A
12345